欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/0309/002
药品名称
Pentastarch 10%
活性成分
poly(O-2-hydroxyethyl)starch sodium chloride 109.0 g
剂型
Solution for infusion
上市许可持有人
Baxter Deutschland GmbH Edisonstraße 4 85716 Unterschleißheim
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Pentastarch 10 % "Baxter" - Infusionslösung
Italy (IT)
Belgium (BE)
France (FR)
Portugal (PT)
许可日期
2001/11/29
最近更新日期
2012/08/10
药物ATC编码
B05AA07 hydroxyethylstarch
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Generic Article 4.8(a)(iii), first paragraph
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final SPC
|
spcen-pentastarch-10-renewal-1006
Date of last change:2010/07/23
Final SPC
|
spcen-pentastarch-6-renewal-1006
Date of last change:2010/07/23
Final Labelling
|
labip-001-pentastarch-10-renewal-1006
Date of last change:2010/07/23
Final Labelling
|
labip-001-pentastarch-6-renewal-090227-1
Date of last change:2010/07/23
Final Labelling
|
labop-001-pentastarch-10-renewal-090227-1
Date of last change:2010/07/23
Final Labelling
|
labop-001-pentastarch-6-renewal-090227
Date of last change:2010/07/23
Final PL
|
palen-pentastarch-10-renewal-1006
Date of last change:2010/07/23
Final PL
|
palen-pentastarch-6-renewal-1006
Date of last change:2010/07/23
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase